GGrantIndex
← Search

DISCOVERY OF A FIRST-IN-CLASS MPP8 ANTAGONIST TO REVERSE LINEAGE PLASTICITY IN BLADDER CANCER

$612,431FY2021Defense Health AgencyDOD

University Of North Carolina At Chapel Hill, Chapel Hill NC

Investigators

View source on USAspending →
DISCOVERY OF A FIRST-IN-CLASS MPP8 ANTAGONIST TO REVERSE LINEAGE PLASTICITY IN BLADDER CANCER · GrantIndex